- Home
- Automated
- List of product information
- DIFFLAM SOLUTION 22.5 MG/15 ML [SIN04232P]
DIFFLAM SOLUTION 22.5 MG/15 ML [SIN04232P]
Active ingredients: DIFFLAM SOLUTION 22.5 MG/15 ML
Product Info
DIFFLAM SOLUTION 22.5 MG/15 ML
[SIN04232P]
Product information
Active Ingredient and Strength | BENZYDAMINE HCL - 22.5 MG/15 ML |
Dosage Form | MOUTHWASH |
Manufacturer and Country | ENSIGN LABORATORIES PTY LTD - AUSTRALIA |
Registration Number | SIN04232P |
Licence Holder | INOVA PHARMACEUTICALS (SINGAPORE) PTE. LIMITED |
Forensic Classification | PHARMACY ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | A01AD02 |
INDICATIONS
Difflam® is indicated for the relief of painful conditions of the oral cavity including: tonsillitis, sore throat, radiation mucositis, aphthous ulcers, post orosurgical and periodontal procedures.
DOSAGE AND ADMINISTRATION
Difflam® should generally be used undiluted, but if stinging occurs it may be diluted with water.
The solution should be expelled from the mouth after use.
Uninterrupted treatment should not exceed seven days.
Dosage in Adults
When used as a gargle, the usual dose Difflam® is 15 mL (approximately one tablespoon) which should be gargled for at least 30 seconds at 1½ to 3 hourly intervals, as needed.
When used as a rinse for oral lesions, the usual dose is again 15 mL (approximately one tablespoon) which should be held in the mouth and swirled around for at least 30 seconds, with repeat use every 1½ to 3 hours throughout the day.
Dosage in Children
5–15 mL as a gargle if able to do so, or as an oral rinse.
With Impaired Renal Function
Since absorbed benzydamine and its metabolites are excreted in the urine, the possibility of systemic effects should be considered in patients with severe renal impairment.
With Impaired Liver Function
Since absorbed benzydamine is highly metabolised in the liver, the possibility of systemic effects should be considered in patients with severe hepatic impairment.
CONTRAINDICATIONS
Difflam® is contraindicated in patients with known hypersensitivity to benzydamine or to any of the components of the vehicle.
